Two Sigma Investments, LP Precision Biosciences Inc Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.29 - $0.45 $95,926 - $148,851
330,780 New
330,780 $119,000
Q2 2023

Aug 14, 2023
BUY
$0.52 - $0.91 $39,098 - $68,422
75,190 Added 592.93%
87,871 $46,000
Q1 2023

May 15, 2023
BUY
$0.7 - $1.41 $8,876 - $17,880
12,681 New
12,681 $9,000
Q3 2022

Nov 14, 2022
BUY
$1.22 - $40.8 $139,868 - $4.68 Million
114,646 Added 948.82%
126,729 $165,000
Q2 2022

Aug 15, 2022
SELL
$1.15 - $3.34 $246,796 - $716,784
-214,606 Reduced 94.67%
12,083 $19,000
Q1 2022

May 16, 2022
BUY
$2.96 - $7.76 $670,999 - $1.76 Million
226,689 New
226,689 $698,000
Q4 2021

Feb 14, 2022
SELL
$7.4 - $11.66 $1.42 Million - $2.23 Million
-191,543 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$9.18 - $14.15 $366,640 - $565,136
39,939 Added 26.34%
191,543 $2.21 Million
Q2 2021

Aug 16, 2021
BUY
$8.07 - $12.52 $1.22 Million - $1.9 Million
151,604 New
151,604 $1.9 Million
Q4 2020

Feb 16, 2021
SELL
$5.98 - $12.47 $227,126 - $473,623
-37,981 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$4.65 - $8.73 $77,069 - $144,691
-16,574 Reduced 30.38%
37,981 $234,000
Q2 2020

Aug 14, 2020
SELL
$4.66 - $8.7 $5,587 - $10,431
-1,199 Reduced 2.15%
54,555 $454,000
Q1 2020

May 15, 2020
BUY
$5.05 - $15.01 $281,557 - $836,867
55,754 New
55,754 $336,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $584M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email